GWSG
SGMO

GPS Wealth Strategies Group’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

GPS Wealth Strategies Group’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-100
Closed -$87 – 1435
2024
Q3 		$87 Hold
100
– – ﹤0.01% 1372
2024
Q2 		$36 Hold
100
– – ﹤0.01% 1345
2024
Q1 		$67 Buy
+100
New +$73 ﹤0.01% 1234

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

GPS Wealth Strategies Group's SGMO Position: Q4 2024 in Review

GPS Wealth Strategies Group sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2024, closing a stake of 100 shares — an estimated $87 sold.

GPS Wealth Strategies Group first reported a position in SGMO in Q1 2024 and held it in 3 quarters. The position peaked at $87 in Q3 2024. 128 funds tracked by Wall St. Rank hold SGMO as of Q4 2024.

  • GPS Wealth Strategies Group reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2024 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 100 SANGAMO THERAPEUTICS INC shares in Q4 2024, an estimated $87.
  • GPS Wealth Strategies Group first reported a position in SANGAMO THERAPEUTICS INC in Q1 2024 and held it in 3 quarters.
  • GPS Wealth Strategies Group's SANGAMO THERAPEUTICS INC position peaked at $87 in Q3 2024.
  • 128 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2024.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2024, filed 24 Jan 2025.